KYNB.OQ - Kyntra Bio Inc
William Blair & Company

Investigator-Sponsored Study Showed Feasibility of Combining Xtandi and FG-3246; Monotherapy Data Slated for Second Half

公司
KYNB.OQ
日期
2026-02-24
分析师
Andy T. Hsieh, PHD
页数
6 页
需要登录
请登录后购买研报或生成音频内容。